16.97
-0.45
(-2.58%)
At close: January 31 at 4:00:01 PM EST
17.49
+0.52
+(3.06%)
After hours: January 31 at 6:40:11 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARLOW JAMES F. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 13,131 |
| CHIVUKULA PADMANABH Chief Operating Officer | Sale | Oct 15, 2024 | 435,334 |
| FARRELL PETER CRAIG Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 98,696 |
| HOLMES EDWARD W. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| KUMMERFELD KEITH C Officer | Sale | Jul 14, 2023 | 950 |
| MARANTZ JING L. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| MARKELS JOHN Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| MARQUET MAGDA Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 28,073 |
| SASSINE ANDY H Chief Financial Officer | Sale | Jun 12, 2024 | 220,526 |
Related Tickers
ADCT ADC Therapeutics SA
1.6800
-2.33%
NTLA Intellia Therapeutics, Inc.
10.32
-1.81%
IONS Ionis Pharmaceuticals, Inc.
31.90
-4.26%
MIRM Mirum Pharmaceuticals, Inc.
48.88
+0.91%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
EDIT Editas Medicine, Inc.
1.3100
-4.38%
FDMT 4D Molecular Therapeutics, Inc.
5.60
0.00%
HRMY Harmony Biosciences Holdings, Inc.
38.77
-1.95%
DNLI Denali Therapeutics Inc.
23.30
-1.19%
STOK Stoke Therapeutics, Inc.
11.48
+4.46%